Last updated on April 18, 2014 at 7:09 EDT

Latest Robert Heiden Stories

2012-10-25 15:24:34

BALTIMORE, Oct. 25, 2012 /PRNewswire/ -- The healthcare fraud case that Boehringer Ingelheim Pharmaceuticals Inc. settled today with the government for $95 million was due in large measure to a former Boehringer Ingelheim sales representative-turned-whistleblower who made extraordinary efforts to stop Boehringer Ingelheim's pharma marketing practices that allegedly defrauded Medicare and other government healthcare programs and promoted uses of its drugs that endangered patients'...

2012-03-28 06:26:10

PLANO, Texas, March 28, 2012 /PRNewswire/ -- Hawthorn Pharmaceuticals Inc. and its parent company, Cypress Pharmaceutical Inc., have paid the federal government and certain states a total of $2.8 million to settle a whistleblower lawsuit filed by Phillips & Cohen LLP that alleged Hawthorn falsely marketed unapproved prescription drugs as being eligible for reimbursement by Medicaid and other government health care programs. An even bigger result of the "qui tam" (whistleblower) lawsuit...